World's Best Scientists 2026 revealed!
Award Badge
Rising Stars
2025
Award Badge
Molecular Biology
Iran
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Rising Stars 60 161 161 7 7 542 13776
Molecular Biology 64 1749 1571 2 2 394 14040

Amir Avan publications per year

The chart shows the history of publications by Amir Avan between 2012 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Amir Avan published across 14 years, from 2012 to 2025, averaging 38.4 papers a year. Output peaked at 99 publications in 2019. 51 of the 538 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 2012 to 2025. Vertical axis: number of publications, 0 to 99. Peak 99 publications in 2019. 2012: 8 publications 2013: 13 publications 2014: 27 publications 2015: 14 publications 2016: 33 publications 2017: 60 publications 2018: 79 publications 2019: 99 publications 2020: 45 publications 2021: 46 publications 2022: 24 publications 2023: 39 publications 2024: 35 publications 2025: 16 publications
2012 2025

538 publications in total across all disciplines

View publications per year as a table
Amir Avan: publications per year, 2012 to 2025
Year Publications
2012 8
2013 13
2014 27
2015 14
2016 33
2017 60
2018 79
2019 99
2020 45
2021 46
2022 24
2023 39
2024 35
2025 16
Total 538
Download as CSV

Amir Avan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Amir Avan sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 387–396 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 394 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24 394
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Amir Avan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Amir Avan sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 64–65 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131 64
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Iran Leader Award
  • 2025 - Research.com Rising Stars Award

Overview

Amir Avan is affiliated with Mashhad University of Medical Sciences in Iran and has a significant presence in the fields of medicine and biochemistry, genetics, and molecular biology. Their research output includes 216 publications in medicine and 154 in biochemistry, genetics, and molecular biology, with notable contributions across various subfields such as molecular biology, oncology, cancer research, surgery, and genetics.

Their research covers a diverse spectrum of cancer-related topics and molecular mechanisms, reflecting an emphasis on pancreatic and hepatic oncology, colorectal cancer, nanoplatforms for cancer theranostics, and the role of microRNA in disease regulation.

  • Pancreatic and Hepatic Oncology Research
  • Cancer-related molecular mechanisms research
  • Colorectal Cancer Treatments and Studies
  • Nanoplatforms for cancer theranostics
  • MicroRNA in disease regulation
  • Cancer Research and Treatments
  • Intestinal and Peritoneal Adhesions

Amir Avan has frequently published in venues such as:

  • Current Pharmaceutical Design
  • PubMed
  • Life Sciences
  • Letters in Drug Design & Discovery
  • Current Cancer Drug Targets

Among their recent papers are:

  • Early-stage cervical cancer diagnosis based on an ultra-sensitive electrochemical DNA nanobiosensor for HPV-18 detection in real samples, 2020, Journal of Nanobiotechnology
  • Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC), 2021, Cancers
  • Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer, 2020, Gene
  • Bacteria and cancer: Different sides of the same coin, 2020, Life Sciences
  • The bacterial instrument as a promising therapy for colon cancer, 2020, International Journal of Colorectal Disease

Collaborations play a notable role in their work, with frequent co-authors including:

  • Majid Khazaei
  • Gordon A. Ferns
  • Seyed Mahdi Hassanian
  • Fereshteh Asgharzadeh
  • Seyedeh Elnaz Nazari

The range of research topics, publication venues, and co-author network indicates an interdisciplinary approach predominantly focused on cancer biology, therapeutic strategies, and molecular diagnostics within oncology and related biomedical sciences.

Best Publications

  • The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials

    Maryam Moradi Binabaj;Afsane Bahrami;Soodabeh ShahidSales;Marjan Joodi

  • Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

    Abolfazl Avan;Tjeerd J. Postma;Cecilia Ceresa;Amir Avan

  • Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.

    R Nedaeinia;M Manian;M H Jazayeri;M Ranjbar

  • Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.

    Faezeh Ghasemi;Mojtaba Shafiee;Zarrin Banikazemi;Mohammad Hossein Pourhanifeh

  • Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.

    Afsane Bahrami;Forouzan Amerizadeh;Soodabeh ShahidSales;Majid Khazaei

  • Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer

    Reyhaneh Moradi Marjaneh;Farzad Rahmani;Seyed Mahdi Hassanian;Nastaran Rezaei

  • MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

    Hamed Mirzaei;Sharareh Gholamin;Soodabeh Shahidsales;Amirhossein Sahebkar

  • Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia

    M Maftouh;A Avan;R Sciarrillo;Carlotta Granchi

  • Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice

    Amir Avan;Seyedeh Belin Tavakoly Sany;Majid Ghayour-Mobarhan;Hamid Reza Rahimi

  • Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.

    Safieh Ebrahimi;Mina Hosseini;Soodabeh Shahidsales;Mina Maftouh

  • The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs

    Afsane Bahrami;Amir Aledavood;Kazem Anvari;Seyed Mahdi Hassanian

  • Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer.

    Atena Soleimani;Farzad Rahmani;Gordon A. Ferns;Mikhail Ryzhikov

  • Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress: Wnt PATHWAY INCRC

    Afsane Bahrami;Forouzan Amerizadeh;Soodabeh ShahidSales;Majid Khazaei

  • Early detection of colorectal cancer: from conventional methods to novel biomarkers

    Nasimeh Vatandoost;Jahanafrooz Ghanbari;Mahboobeh Mojaver;Amir Avan

  • Hereditary breast cancer; Genetic penetrance and current status with BRCA.

    Morteza Mahdavi;Mohammadreza Nassiri;Mohammad Mahdi Kooshyar;Masoume Vakili-Azghandi

  • The Potential Value of the PI3K/Akt/mTOR Signaling Pathway for Assessing Prognosis in Cervical Cancer and as a Target for Therapy

    Afsane Bahrami;Malihe Hasanzadeh;Seyed Mahdi Hassanian;Soodabeh ShahidSales

  • Podophyllotoxin: a novel potential natural anticancer agent.

    Hamidreza Ardalani;Amir Avan;Majid Ghayour-Mobarhan

  • Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives

    Hamed Mirzaei;Sara Khataminfar;Saeid Mohammadparast;Soudabeh Shahid Sales

  • Genetic and epigenetic factors influencing vitamin D status.

    Afsane Bahrami;Hamid Reza Sadeghnia;Seyed‐Amir Tabatabaeizadeh;Hamidreza Bahrami‐Taghanaki

  • Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

    Amir Avan;Francesco Crea;Elisa Paolicchi;Niccola Funel

Frequent Co-Authors

Gordon A. Ferns
Gordon A. Ferns Brighton and Sussex Medical School
Elisa Giovannetti
Elisa Giovannetti VU University Medical Center
Godefridus J. Peters
Godefridus J. Peters Gdańsk Medical University
Hamed Mirzaei
Hamed Mirzaei Kashan University of Medical Sciences
Amirhossein Sahebkar
Amirhossein Sahebkar Mashhad University of Medical Sciences
William C S Cho
William C S Cho Hospital Authority
Henk M.W. Verheul
Henk M.W. Verheul Radboud University
Majid Darroudi
Majid Darroudi Mashhad University of Medical Sciences
Mahmoud Reza Jaafari
Mahmoud Reza Jaafari Mashhad University of Medical Sciences
Michele Milella
Michele Milella University of Verona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology in the USA opens up a range of related online degree and career options. Students interested in communication sciences may consider joining asha accredited online slp programs, which offer flexible learning while ensuring professional standards. For those with a non-SLP background, slp bridge programs provide the necessary foundation to transition into speech-language pathology roles.

If you are considering a career switch into healthcare, pursuing a nursing degree is also a viable option. Many universities now offer non nursing degree to bsn online programs, which allow you to fast-track your way to becoming a registered nurse—even if your undergraduate studies were in another field.

Additionally, careers like psychiatric nurse practitioner are in high demand. When evaluating your earning potential, it's helpful to review information on psychiatric nurse practitioner salary by state. These pathways demonstrate that molecular biology graduates have many options for further education and specialized healthcare roles.

Best Scientists Citing Amir Avan

Trending Scientists

Recently Published Articles